INTRODUCTION
von Willebrand factor (vWF) is a multimeric plasma protein that mediates the adhesion of platelets to vascular subendothelium exposed to flowing blood as a consequence of tissue damage (Ruggeri and Ware, 1992) . During this phenomenon exposed vessel-wall extracellular matrix collagens interact with circulating vWF; this binding is mediated by specific amino acid sequences located in the functional Al and A3 vWF domains (Pareti et al., 1987; Kalafatis et al., 1987) . Subsequently, at sufficiently elevated shear forces, collagen-bound vWF interacts with the glycoprotein lb (GPIb) receptor located on circulating platelets via sequences close to or located within the vWF Al loop, which itself is shaped by a disulphide bridge between the cysteine residues 509 and 695 (Meyer and Girma, 1993) .
It is believed that high shear forces induce a conformational change in the vessel-wall-associated vWF, accompanied by exposure of the platelet GPIb-binding site (Bolhuis et al., 1981) . Under in vitro conditions of low shear forces, this binding can be simulated by two non-physiological mediators, ristocetin and botrocetin (Coller, 1985) . Ristocetin is a glycopeptide antibiotic, synthesized by the actinomycete Nocardia lurida, that spontaneously dimerizes with an equilibrium constant around 1.1 mg/ml (Waltho and Williams, 1989) . The flocculation of fibrinogen and agglutination of platelets observed in the presence of ristocetin are believed to be the result of cross-linking induced by ristocetin dimers that bridge proline-rich f-turns in separate protein molecules (Scott et al., 1991) . Two-chain botrocetin on the other hand, a 32 kDa protein isolated from the venom of the snake Bothrops jararaca, forms a soluble complex with vWF (Fujimura et al., 1991) . In addition, although quite a large number of anti-vWF monoclonal antibodies have been reported low concentrations of poly(Pro-Gly-Pro), which is known to complex ristocetin dimers. Mechanistic analysis of the inhibition of vWF binding by the recombinant vWF fragment Leu504-Ser728 (VCL), which covers the entire Al loop, revealed an affinity of VCL for GPIb comparable with that of the botrocetin-vWF complex for GPIb, and identified a specific but 20-fold lower affinity of VCL in the presence of ristocetin. The proline-rich peptides flanking the vWF Al loop, Cys474-Val489 and Leu694-Asp709, inhibited vWF binding semispecifically by competitively interfering with the formation of the GPIb-vWF complex rather than by complexation of free ristocetin dimers. In conclusion, ristocetin-promoted binding of vWF to its GPIb receptor results from charge neutralization and interactions involving proline residues in the vicinity of the natural interaction sites present on both GPIb and the Al domain of vWF.
to block ristocetin-induced platelet aggregation by inhibition of vWF binding to GPIb (Fujimura et al., 1992 ), we have recently described an anti-vWF monoclonal antibody, lClE7, that is capable of positively modulating the interaction of vWF with GPIb, i.e. by lowering the ristocetin requirements during ristocetin-induced platelet aggregation (Tornai et al., 1993) .
Three vWF sequences are at present believed to be involved in the binding of vWF to GPIb: two non-contiguous sequences Cys474-Pro488 and Leu694-Pro708 (Mohri et al., 1988 (Mohri et al., , 1989 , which flank the Al loop, and a third sequence (Asp514-Glu542), which resides inside the Al loop (Berndt et al., 1992) . Because the synthetic peptide Asp514-Glu542 inhibits ristocetin-independent binding of both asialo-vWF and bovine vWF to GPIb, this sequence is thought to constitute a major part of the GPIbbinding site on vWF (Berndt et al., 1992 ). This hypothesis is further supported by the finding that three discontinuous sequences within the Al loop located between Asp539 and Cys643 are involved in complex-formation of vWF with botrocetin . In contrast with the well-understood mechanism underlying botrocetin-mediated vWF binding, the exact mechanism by which ristocetin mediates vWF binding to GPIb remains to be elucidated. The finding that the polyanionic aurin tricarboxylic acid (ATA) binds to the botrocetin interaction site in the Al loop, and not only competes with botrocetinmediated vWF binding to GPIb but also ristocetin-mediated binding, also points to the importance ofthe Al loop in ristocetinmediated vWF binding to GPIb (Girma et al., 1992) . The observation that a vWF proteolytic fragment III-T2, which almost completely lacks the Al loop, can still compete with ristocetin-dependent binding of native vWF as well as asialovWF to GPIb (Mohri et al., 1989) suggests that the sequences that flank the Al loop contribute also to the binding to GPIb. (Gralnick et al., 1992) , ATA, the vWF peptides Cys474-Val489 and Leu694-Asp709, poly-L-lysine and poly(Pro-Gly-Pro). The use of these well-defined inhibitors has enabled us to validate experimentally the proposed mechanism for ristocetin-promoted binding of vWF to GPIb.
MATERIALS AND METHODS Purification of GPlb
Isolated platelets were successively frozen in the presence of 1 mM EDTA and thawed three times and pelleted at 24000 g (17000 rev./min). On solubilization of the pellet in 10 mM Tris/HCl buffer, pH 7.4, containing 1 mM EDTA and 10 mM CHAPS (Sigma, St. Louis, MO, U.S.A.) followed by centrifugation, the supernatant was loaded on a column of CNBrconjugated AP-1 Sepharose; the anti-GPIb monoclonal antibody AP-1 used for this conjugation was generously provided by Dr. Kunicki, Scripps Research Institute, La Jolla, CA, U.S.A. On loading, this affinity column was washed with 10 mM Hepes buffer, pH 7.5, containing 1 mM EDTA and 2 mM CHAPS. The GPIb was isolated by elution with 2 M KSCN added to the wash buffer, and after dialysis it was stored at -80 'C. When tested by SDS/PAGE (Laemmli, 1970) , the eluted and reduced proteins displayed three bands characteristic of both GPIb chains and the associated GPIX band, in addition to traces of bands corresponding to glycocalicin.
Purification of vWF vWF was purified from human plasma cryoprecipitate by reprecipitation and bentonite-mediated fibrinogen depletion, followed by gel filtration on a Sepharose 4B-CL column (2.6 cm x 95 cm) . On reduced SDS/ polyacrylamide gels, over 90 % of the isolated protein appeared as a single 250 kDa band. Unless indicated, all experiments were carried out with a single preparation, selected because of its low degree of non-specific binding during e.l.i.s.a. (see below). On collection of the gel-filtration eluate into three fractions of decreasing molecular mass, vWF entities of progressively diminishing degree of multimerization were collected. AsialovWF was prepared from purified vWF by digestion with 0.2 unit of Clostridium perfringens neuraminidase (Sigma)/mg of vWF for 3 h at 37 'C, after which the neuraminidase was removed by gel filtration on the Sepharose 4B-Cl column.
Studies of interaction between vWF and GPlb
The interaction between purified vWF and GPIb was studied in an e.l.i.s.a. configuration. Purified GPIb was coated on the wells of microtitre plates at 2 ,tg/ml (200 ,ul/well) for 48 h at 4°C in 10 mM Tris/HCl, pH 7.5, containing 10 mM NaCl and 10 mM NaNa. After blocking of non-adsorbed sites with BSA (10 mg/ml), vWF (0-50 jug/ml) was incubated in the plates with ristocetin (0-2 mg/ml; Paesel-Lorei, Frankfurt, Germany) or botrocetin (0-1 ,ug/ml; Pentapharm LTI, Basel, Switzerland), in some experiments supplied with the home-made anti-vWF antibody IClE7 (0-50 ug/ml) to positively modulate binding of vWF (Tornai et al., 1993) . Protein mixtures were pipetted into the microtitre-plate wells before the addition of ristocetin or botrocetin. All dilutions were made in P-BS containing 0.1 0% BSA and 0.002 % Tween 80. Control incubations were performed in the presence of identical concentrations of an irrelevant monoclonal antibody 7C7B3. In order to distinguish between specific, i.e. GPIb-dependent, and non-specific binding, GPIbcoated plates were presaturated with AP-1, which, when bound to the N-terminal loop of GPIb, specifically prevents binding of vWF (Montgomery et al., 1983) . To study further the specificity of the binding and to analyse mechanistically the contribution of various vWF domains in the interaction with GPIb, botrocetinand ristocetin-mediated vWF binding were studied in the presence of potential inhibitors such as the polymers (all obtained from Sigma) poly(Pro-Gly-Pro) (5.4 kDa; 0-10 ,uM), poly-Llysine (3.97 kDa; 0-100 ,uM) and ATA (0.473 kDa; [0] [1] [2] [3] uM (Tornai et al., 1991) .
Flocculation
Agglutination of vWF multimers of various size (75 ,tg/ml) by ristocetin (1.6 mg/ml) was studied in a Pye-Unicam SP 1800 spectrophotometer, by continuously recording the lightscattering signal at 600 nm, in the absence or presence ofantibody lC1E7 (50 ,tg/ml) [GPIb-vWF-B] via an undefined staining constant (k) which, in addition to the amount of bound vWF, depends on the substrate concentration and the staining time:
(1) KA1 The total GPLb concentration can be obtained using the following expression:
[GPIb]°= [GPIb] (Figure 2b, inset) . Mechanistic analysis of this inhibition (Figure 2b ) identified an apparent inhibition constant Ki = 1.1 + 0.2,M for the ATA-vWF interaction, a value reflecting an even higher affinity than that expected from binding studies performed with platelets (Girma et al., 1992) . We recently reported that the anti-vWF antibody lCl E7 causes a conformational change in the vWF molecule, which is accompanied by an enhanced affinity of the high vWF multimers for GPIb (Tornai et al., 1993) . In contrast with the weak effect that a control monoclonal antibody exerts, in the presence of an excess of lClE7, the botrocetin-mediated binding of vWF is enhanced and saturates at a higher plateau value (Figure 2c ). Simultaneously performed binding studies on GPIb-coated plates pretreated with the anti-GPIb antibody AP-1 showed greatly reduced binding (Figure 2c (Gralnick et al., 1992) . As shown in the inset of Figure  2( (Scott et al., 1991) . Incubation of GPIb in the e.l.i.s.a. with various concentrations of both ristocetin and vWF produced saturation curves for GPIb-bound vWF similar to those previously described for the binding of vWF to particle-immobilized GPIb (Berndt et al., 1988) . However, at increasing concentrations of ristocetin, non-specific vWF binding progressively predominated, as evidenced by the larger proportions of AP-1 insensitive binding (Figure 3a) . The nonspecific character of this binding at ristocetin concentrations exceeding 0.4 mg/ml was confirmed during incubations in plates not coated with GPIb ( Figure 3b ). Therefore, in order to avoid non-specific ristocetin-mediated vWF binding to coated proteins, the experimental ristocetin concentrations were limited to 0.4 mg/ml, ristocetin-dependent vWF binding to GPIb being specific below this concentration, when binding was studied in the presence of both 1 Cl E7 and the control antibody 7C7B3. At this concentration, ristocetin induced no flocculation of vWF, as judged from protein measurements in the centrifuged supernatant of incubation mixtures of vWF (75 ,ug/ml) and various concentrations of ristocetin (0-2 mg/ml). Additive effects were observed between low concentrations of ristocetin and botrocetin during vWF binding (Figure 3c) . However, at 0.4 mg/ml ristocetin, the observed binding could be mainly accounted for by ristocetin, vWF binding to GPIb could only be observed at low ristocetin concentrations, i.e. on addition of 1ClE7 a shift of the GPIb saturation curves to lower vWF concentrations could only be observed at ristocetin concentrations up to 0.25 mg/ml ( Figure  4b ). These experiments suggest that, above this concentration, although vWF binding is still specific (i.e. AP-1-sensitive), ristocetin induces vWF binding to GPIb independently of the binding site present on the vWF Al loop, which is modulated by lClE7 (as observed both with botrocetin and at low ristocetin levels). The low degree of binding observed for high [vWF] °in the absence of ristocetin (Figure 4 , dashed lines) was not modified by the addition of lCIE7, indicating that this binding was nonspecific and confirming that, in the absence of ristocetin, specific vWF binding to GPIb is negligible.
Mechanism of ristocetin-dependence
In order to define the i-mportance of the Al-loop-independent interaction sites during ristocetin-mediated binding of vWF to GPIb, we analysed mechanistically the ristocetin-dependence of this binding. (Figure 5b ), thus demonstrating high specificity for ristocetin in vWF binding to GPIb.
In view of the finding that the rate of vWF flocculation is limited by the involvement of two ristocetin dimers, the present findings suggest that ristocetin binds to GPIb either via interaction with four ristocetin monomers or, more probably, via binding of two ristocetin dimers (Scott et al., 1991 of the non-specific vWF binding (yielding non-linear doublereciprocal plots) to total vWF binding cannot be neglected (Figure 6a) . Nevertheless, the regression lines constructed between 0.2 and 0.4 mg/ml ristocetin intersected on the y-axis at a single point. In agreement with the participation of two ristocetin dimers, 1 /A versus 1 /[RR]2 plots were linear and also intersected on the y-axis at a single point (Figure 6b ). studies were carried out with substances not expected to be inhibitory at the vWF level. Proline-rich polymers such as poly(Pro-Gly-Pro) have fl-turns that complex the ristocetin dimers that are responsible for protein flocculation (Scott et al., 1991) . We have confirmed that the flocculation of purified highmolecular-mass vWF multimers by ristocetin can indeed be inhibited by poly(Pro-Gly-Pro). The degree of flocculation itself was independent of the presence of 50 ,ug/ml IC1E7 (not shown).
As shown in Figure 7( (Carew et al., 1992) . In addition, positively charged peptides were recently reported to interfere with ristocetin-mediated binding of vWF (Mohri et al., 1993) . Positively charged poly-Llysine was here confirmed to be a competitor during binding of 10 utg/ml vWF in the presence of ristocetin (0.3 mg/ml). As shown in Figure 7( (Mohri et al., 1989; Berndt et al., 1992) . Surprisingly though, plots of 1/A versus the peptide concentration yielded straight lines for both peptides, as shown in Figure 8( Figure 8a ) and with
[vWF]° (Figure 8b ). Repeating the same analysis for the peptide Cys474-Val489 led to the same conclusions, even though this peptide was a 2-3-fold weaker inhibitor. Double-reciprocal plots of A versus [vWF] °confirmed that the peptides behave as competitive inhibitors (Figure 8c ).
Inhibition of ristocetin-induced binding by VCL were linear, yielding a value for K'VCL of 18 + 4 nM (Figure 9a) , reflecting a considerably weaker affinity of VCL for GPIb in the presence of ristocetin than that found during inhibition of botrocetin-mediated vWF binding to GPIb (KVCL = 0.8 nM).
Finally, co-inhibition studies were performed involving both VCL and Leu694-Asp709, at constant concentrations of ristocetin and vWF, to investigate whether VCL and the peptide acted in concert but independently of each other. Under conditions in which the inhibitors act independently, an intersection is expected at [vWF] = -K'VCL' i.e. at the concentration predicted for inhibition experiments performed with VCL as the exclusive inhibitor. Indeed, during this type of complex inhibition ( Figure  9b ), a linear relationship was observed for I/A versus [VCL]°p lots when constructed for various concentrations of Leu694-Arg702-Arg704 led to a complete loss of ristocetin-mediated vWF binding to GPIb (Azuma et al., 1993) ; however, this finding needs to be interpreted with caution in view of the structural role played by proline residues.
The VCL fragment is a monomeric vWF fragment corresponding to Leu504-Ser728 which strongly inhibits vWF interaction with GPIb, when mediated by both botrocetin and ristocetin (Gralnick et al., 1992) . We confirmed during botrocetinmediated vWF-binding studies that this fragment by itself bound to GPIb with high affinity. This conclusion came from the fact that an intersection was found in the 1/A versus [VCL]°plots. Indeed, ifVCL binding to GPIb was also mediated via botrocetin, such plots would have resulted in parallel rather than intersecting lines. A similar conclusion holds for the binding of VCL in the presence of ristocetin, which would be described by parallel 1/A versus [VCL]°plots if VCL binding to GPIb were mediated via ristocetin. However, the apparent affinity of VCL for GPIb was considerably lower in the presence of ristocetin than in the presence of botrocetin (Figure lb) . This can only be explained if ristocetin dimer binding occurs in the negatively charged Nterminal domain of GPIb, i.e. that part of the receptor at which the VCL fragment also has to bind, but it also suggests that additional sequences in VCL are required for the inhibition of ristocetin-mediated vWF binding, in comparison with those involved in the inhibition of botrocetin-mediated vWF binding.
In conclusion, the present study examined ristocetin-induced vWF binding to GPIb by mechanistic analysis. We found that the basis of specific vWF binding to GPIb is the participation of two ristocetin dimers which bridge the two proteins as a result of both charge neutralization and interactions with proline residues in the vicinity of the natural binding sites on GPIb and the Al domain of vWF.
